Transferring control of Southwestern Vermont Health Care to Dartmouth Health could be a win-win for the Bennington area; southwestern Vermont could surely use the Dartmouth Health resources. However, we must pay attention to the downside.
The addition of oxaliplatin does not extend progression-free survival in elderly patients with metastatic colorectal cancer and in fact, can lead to more severe adverse events.